A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/198 (2006.01)
Patent
CA 2474813
A novel dosage form of L-Methionine S-Sulfoximine for the treatment of diseases and conditions susceptible to the inhibition of glutamine synthetase is disclosed. The novel dosage form should not exceed 10 mg/kg by body weight over a one week period, and preferably should not exceed 8 mg/kg, and more preferably should not exceed 5 mg/kg, and most preferably should not exceed 2.5 mg/kg.
L'invention concerne une nouvelle forme posologique de L-méthionine S-sulfoximine destinée à traiter des maladies et des affections répondant à une inhibition de glutamine synthétase. Cette nouvelle forme posologique ne devrait pas dépasser 10 mg/kg de poids corporel sur une période d'une semaine ; de préférence, elle ne devrait pas dépasser 8 mg/kg, mieux encore 5 mg/kg, et idéalement 2,5 mg/kg.
Brusilow Saul W.
Koehler Raymond C.
Traystman Richard J.
Bereskin & Parr
Mso Pharma Llc
LandOfFree
A novel dosage form of l-methionine s-sulfoximine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with A novel dosage form of l-methionine s-sulfoximine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and A novel dosage form of l-methionine s-sulfoximine will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1934072